Inventiva Market Capitalization from 2010 to 2024
| IVA Stock | USD 2.68 0.04 1.52% |
Check Inventiva financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inventiva's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 5.4 M or Selling General Administrative of 7.1 M, as well as many indicators such as Price To Sales Ratio of 10.28, Dividend Yield of 0.0 or Days Sales Outstanding of 268. Inventiva financial statements analysis is a perfect complement when working with Inventiva Valuation or Volatility modules.
Inventiva | Market Capitalization |
Latest Inventiva's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Inventiva Sa over the last few years. It is Inventiva's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inventiva's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 229.75 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Inventiva Market Capitalization Regression Statistics
| Arithmetic Mean | 154,067,090 | |
| Geometric Mean | 127,729,890 | |
| Coefficient Of Variation | 76.69 | |
| Mean Deviation | 82,024,317 | |
| Median | 86,318,022 | |
| Standard Deviation | 118,156,867 | |
| Sample Variance | 13961T | |
| Range | 386.3M | |
| R-Value | 0.54 | |
| Mean Square Error | 10643.6T | |
| R-Squared | 0.29 | |
| Significance | 0.04 | |
| Slope | 14,278,880 | |
| Total Sum of Squares | 195454.6T |
Inventiva Market Capitalization History
About Inventiva Financial Statements
Inventiva stakeholders use historical fundamental indicators, such as Inventiva's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Inventiva investors may analyze each financial statement separately, they are all interrelated. For example, changes in Inventiva's assets and liabilities are reflected in the revenues and expenses on Inventiva's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Inventiva Sa. Please read more on our technical analysis and fundamental analysis pages.
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis , mucopolysaccharidoses , and other diseases. Inventiva S.A. was founded in 2011 and is based in Daix, France. Inventiva is traded on NASDAQ Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Inventiva Sa offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inventiva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inventiva Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inventiva Sa Stock:Check out the analysis of Inventiva Correlation against competitors. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inventiva. If investors know Inventiva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inventiva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.14) | Revenue Per Share 0.383 | Quarterly Revenue Growth (0.59) | Return On Assets (1.13) | Return On Equity (16.43) |
The market value of Inventiva Sa is measured differently than its book value, which is the value of Inventiva that is recorded on the company's balance sheet. Investors also form their own opinion of Inventiva's value that differs from its market value or its book value, called intrinsic value, which is Inventiva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inventiva's market value can be influenced by many factors that don't directly affect Inventiva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inventiva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inventiva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inventiva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.